Newsroom
Sorted by: Latest
-
FDA Grants Accelerated Approval to Gilead’s Hepcludex® (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus (HDV)
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Hepcludex® (bulevirtide-gmod) 8.5 mg for the treatment of adults living with chronic hepatitis delta virus (HDV) infection, making it the first and only approved treatment for HDV in the United States. The FDA granted accelerated approval to Hepcludex based on reductions in HDV RNA and normalization of alanine aminotrans...
-
COTY Deadline: Rosen Law Firm Urges Coty Inc. (NYSE: COTY) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of common stock of Coty Inc. (NYSE: COTY) between November 5, 2025 and February 4, 2026. Coty describes itself as a company that “together with its subsidiaries, manufactures, markets, distributes, and sells branded beauty products worldwide.”For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.The Alleg...
-
Securities Fraud Investigation Into Claritev Corporation (CTEV) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV) on behalf of investors concerning the Company’s possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON CLARITEV CORPORATION (CTEV), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.What Is The Investigation About?On May 14, 2026, the Capitol Forum reported the U.S. Department of...
-
Best’s Commentary: Insurers Better Prepared for Rare Disease Outbreak Amid Lessons From COVID-19
OLDWICK, N.J.--(BUSINESS WIRE)--Outbreaks of the Ebola virus and Andes hantavirus are putting a renewed focus on the insurance implications of rare communicable disease spreads and the need for proactive risk management, according to a new AM Best commentary. The Best’s Commentary, “Insurers Better Prepared For Rare Disease Outbreak Amid Lessons From COVID-19,” notes that health experts have said neither virus poses an immediate global threat nor is expected to spread anywhere near the scale of...
-
CORRECTING and REPLACING PCI Pal Raises the Bar for Payment Security With SOC2 Type II with HIPAA/HITECH Attestation
CHARLOTTE, N.C.--(BUSINESS WIRE)--Please replace the release dated April 14, 2026 with the following corrected version to replace references to HITRUST with references to HIPAA/HITECH. The updated release reads: PCI PAL RAISES THE BAR FOR PAYMENT SECURITY WITH SOC2 TYPE II WITH HIPAA/HITECH ATTESTATION PCI Pal® (LON: PCIP), the global provider of secure payment solutions, has further strengthened its position as a trusted enterprise partner with the achievement of SOC 2 Type II attestation, de...
-
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) investors concerning the Company’s possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON GE HEALTHCARE TECHNOLOGIES INC. (GEHC), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened...
-
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA) investors concerning the Company’s possible violations of the federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON AZENTA, INC. (AZTA), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.What Happened?On May 5, 2026, Azenta released its second quar...
-
Securities Fraud Investigation Into Zoetis Inc. (ZTS) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS) investors concerning the Company’s possible violations of the federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON ZOETIS INC. (ZTS), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.What Happened?On May 7, 2026, Zoetis reported financial results for...
-
Balfour Beatty Communities and U.S. Army Fort Gordon Celebrate First New Homes in $50 Million Housing Investment
FORT GORDON, Ga.--(BUSINESS WIRE)--Balfour Beatty Communities, a longtime partner of the Department of Defense, joined U.S. Army Fort Gordon leadership and military families on Wednesday, May 20 to celebrate the completion of the first new homes at Pine Tree Terrace, part of an over $50 million housing investment at Providence Family Homes, the installation’s privatized military housing community. The ribbon‑cutting ceremony marked a significant milestone in Balfour Beatty Community’s long‑term...
-
HSBC Bank Plc UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- 22-May-2026 Issue: Coventry Building Society, CB Series 5 XS2498152920 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 01-May-2026 Date To: 01-June-2026 Record Date: 29-May-2026 Value Date: 01-June-2026 Benchmark Rate: 3.7354% Margin: 0.53% Total Rate: 4.2654% Floor: 0% Number of Days: 31 Day Count: Actual / 365 (Fixed) Interest Frequency: Monthly Denomination: GBP 1,000.00 Amo...